Evidence map›Paper›PMID 31564022›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2020

Health-related quality of life and depressive symptoms in Friedreich ataxia.

Javier Pérez-Flores, Atteneri Hernández-Torres, Fernando Montón, Antonieta Nieto

Abstract read
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Iron chelators: as therapeutic agents in diseases.Annals of medicine and surgery (2012) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Friedreich ataxia: clinical features and new developments.Neurodegenerative disease management · 2022
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Javier Pérez-FloresSchool of Psychology, Universidad de La Laguna, La Laguna, 38205, Tenerife, Spain.
Atteneri Hernández-TorresSchool of Psychology, Universidad de La Laguna, La Laguna, 38205, Tenerife, Spain.
Fernando MontónSchool of Psychology, Universidad de La Laguna, La Laguna, 38205, Tenerife, Spain.
Antonieta NietoSchool of Psychology, Universidad de La Laguna, La Laguna, 38205, Tenerife, Spain. anieto@ull.edu.es.ORCID http://orcid.org/0000-0002-7115-9268
Universidad de La Laguna · ES

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España PSI 2015-67514-P
6 · The paper itself

Abstract

purposeFriedreich ataxia (FRDA) is a chronic, progressive and highly disabling cerebellar degenerative disease. Despite this, little attention has been paid to the health-related quality of life (HRQOL) in this disease. The aim of the present study was to assess FRDA patients' perception of HRQOL and to determine the influence of depression, and demographic and clinical variables.

methodThe sample consisted of 62 patients with genetically confirmed FRDA. The SF-36 Health Survey was used to assess HRQOL. Depressive symptoms were evaluated with the Beck Depression Inventory-II.

resultsFRDA patients' mean scores were significantly lower than the values for the Spanish population in all SF36 dimensions. Average z scores ranged from - 5.5 in physical functioning to - 0.48 in mental health. Age and clinical variables were significant predictors of HRQOL in only several dimensions, whereas BDI scores were able to predict a significant percentage of variance in all SF36 dimensions, except physical functioning.

conclusionsOur study demonstrates the high impact of Friedreich ataxia on quality of life. This impact does not only occur in those aspects most related to motor disability but it is also present in non-motor dimensions. Depressive symptomatology is the most relevant variable for predicting quality of life.

Indexed as

DepressionFriedreich AtaxiaQuality of LifeAdultDemographyFemaleHealth SurveysHumansMaleMental HealthMiddle AgedMotor DisordersPersons with DisabilitiesCerebellumDepressionFriedreich ataxiaNeurological diseasesQuality of life

Identifiers

PMID31564022
OpenAlexW2976049852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.